Company / Assets per Share
X4 Pharmaceuticals, Inc Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$50.97
FY2025
5-year range
$0.87 / $50.97
FY2021-FY2025
Trend
+5727.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +5728% YoY in FY2025, a notable deviation from the 5-year average annual change of +1163%.
Based on SEC 10-K filings.
50.97 in FY2025 with a 5-year CAGR of +46.3%.
Improved from $5.53 to $50.97 over the past 3 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +109.7%
- 5-Year CAGR
- +46.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 5727.9% year-over-year.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.97 | +5727.9% |
| FY2024 | $0.87 | -84.2% |
| FY2022 | $5.53 | -23.0% |
| FY2021 | $7.19 | -5.7% |
| FY2020 | $7.62 | +202.5% |
| FY2018 | $2.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026